EXHIBIT 23.2
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement (FormS-3) and related Prospectus of CRISPR Therapeutics AG for the registration of common shares, debt securities, warrants and units of our report dated March 10, 2017, with respect to the consolidated financial statements of Casebia Therapeutics LLP, included in the Annual Report (Form10-K) of CRISPR Therapeutics AG for the year ended December 31, 2016.
/s/ Ernst & Young LLP |
Boston, Massachusetts |
November 9, 2017 |